Antigen-specific B cells in kidney transplantation

Area of Science:

• Immunology
• Transplantation immunology
• Cellular immunology

Background:

• Human leukocyte antigen (HLA)-specific antibodies are a major cause of rejection in organ transplantation.
• Identifying and quantifying HLA-specific B cells is crucial for understanding immune responses in transplant recipients.

Purpose of the Study:

• To present a novel method for identifying and enumerating human leukocyte antigen (HLA)-specific B cells and their subsets.
• To compare the frequency of these cells in sensitized kidney transplant recipients versus healthy individuals.
• To investigate the in vitro interactions between B cells, T cells, and regulatory T cells in the context of HLA specificity.

Main Methods:

• Utilized biotinylated human leukocyte antigen (HLA) proteins for specific B cell identification and enumeration.
• Employed an indirect antigen-specific enzyme-linked immunosorbent spot (ELISPOT) assay.
• Conducted in vitro experiments to analyze B- and T-cell interactions, including the role of regulatory T cells.

Main Results:

• Successfully developed and validated a method to identify and quantify HLA-specific B cells and subsets.
• Observed a significantly greater frequency of HLA-specific B cells in sensitized kidney transplant recipients compared to healthy volunteers.
• Uncovered the intricate interplay between B cells and T cells, and demonstrated the modulatory effect of regulatory T cells on these interactions in vitro.

Conclusions:

• The described method provides a valuable tool for assessing HLA-specific B cell populations.
• Sensitized kidney transplant recipients exhibit an elevated presence of HLA-specific B cells, highlighting their potential role in transplant rejection.
• In vitro studies reveal complex immune cell interactions, emphasizing the importance of regulatory T cells in modulating immune responses relevant to transplantation.